Extracorporeal Life Support in Cardiogenic Shock Complicating Acute Myocardial Infarction

J Am Coll Cardiol. 2019 May 14;73(18):2355-2357. doi: 10.1016/j.jacc.2019.02.044.
No abstract available

Publication types

  • Clinical Trial, Phase IV
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Extracorporeal Membrane Oxygenation* / adverse effects
  • Extracorporeal Membrane Oxygenation* / methods
  • Female
  • Humans
  • Intention to Treat Analysis
  • Male
  • Middle Aged
  • Myocardial Infarction* / complications
  • Myocardial Infarction* / mortality
  • Shock, Cardiogenic* / etiology
  • Shock, Cardiogenic* / physiopathology
  • Shock, Cardiogenic* / therapy
  • Stroke Volume
  • Survival Analysis
  • Ventricular Dysfunction, Left* / diagnosis
  • Ventricular Dysfunction, Left* / etiology

Associated data

  • ClinicalTrials.gov/NCT02544594